Product Name

Method

Intended Use

Specification

COVID-19 IgG/IgM Rapid Test Kit

Colloidal Gold

COVID-19 IgG/IgM Rapid Test Kit is intended for the qualitative detection of IgM and IgG antibodies against SARS-CoV-2 in human serum, plasma or whole blood from those with clinical suspicion of SARS-CoV-2 infection. It is only used as a supplementary detection index for suspected cases with negative nucleic acid detection of the novel coronaviruses, or used in conjunction with nucleic acid detection in the diagnosis of suspected cases. It cannot be used as a basis for the diagnosis and elimination of COVID-19. It is not suitable for screening in the general population.

25 tests/kit

IFU in English

IFU in German

Clinical Evaluation Report

Influenza A+B/COVID-19 Antigen Rapid Test Device

Colloidal Gold

The Influenza A+B/COVID-19 Antigen Rapid Test Device is a rapid visual immunoassay for the
qualitative, presumptive detection of influenza A and B viral antigens and COVID-19 Antigen
form nasal swab and nasopharyngeal swab specimens. The test is intended for use as an aid in the
rapid differential diagnosis of acute influenza type A and type B virus and COVID-19 infection.

20 tests/kit

SARS-CoV-2 Nucleocapsid (N) Antigen Rapid Test Cassette (Swab)

Colloidal Gold

The product is used for the qualitative detection of SARS-CoV-2 infection. The entire detection process takes only 15-20 minutes, and the operation is simple and sensitive. No instrument required. It can be used for the screening of early infected patients and asymptomatic patients. This method is an effective supplement for nucleic acid detection.　Click to view the operation video

20 tests/kit
1 test/kit

IFU in English

IFU in German

Clinical Evaluation Report

SARS-CoV-2 Nucleocapsid (N) Antigen Rapid Test Cassette

Fluorescence Immunochromatography

The product is used for the qualitative detection of SARS-CoV-2 infection. The entire detection process takes only 15 minutes, and the operation is simple and sensitive. It can be used for the screening of early infected patients and asymptomatic patients. This method is an effective supplement for nucleic acid detection.

20 tests/kit

SARS-CoV-2 Neutralizing Antibody Test Kit

ELISA

The product detects circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain of the viral spike glycoprotein (RBD) with the angiotensin converting enzyme 2 (ACE2) cell surface receptor. The assay detects any antibodies in serum and plasma that neutralize the RBD-ACE2 interaction.

480 tests/kit
96 tests/kit

SARS-CoV-2 Neutralizing Antibody Rapid Test Kit

Fluorescence Immunochromatography

The SARS-CoV-2 neutralizing antibody rapid test kit is a rapid chromatographic immunoassay for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in serum or plasma. It can be used to monitor SARS-CoV-2 infection rates, herd and protective immunity, and to evaluate vaccine efficacy during clinical trials and after mass vaccination.

20 tests/kit

SARS-CoV-2 Antibody Rapid Test Cassette

Colloidal Gold

The SARS-CoV-2 antibody rapid test cassette is a rapid chromatographic immunoassay for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in serum, plasma or whole blood. It can be used for qualitative detection of antibodies produced after inoculation of COVID-19 vaccine, or used as a supplementary detection index for suspected cases negative for SARS-CoV-2 nucleic acid test, or used in conjunction with nucleic acid test in the diagnosis of suspected cases.

20 tests/kit